Porphyrias

Porphyrias

 

Defect in the enzymes of haem synthesis

7 types; 5 liver, 2 erythroid

Classified by whether the predominantly affected organ is the liver or erythron

 

  

Inheritance

Enzyme

Clinical features

ALA dehydrase deficiency

Hepatic

AR

ALA dehydrase

Acute attacks

Acute intermittent

Hepatic

AD

Porphobilinogen deaminase

Acute attacks

Hereditary coprophorphyria

Hepatic

AD

Coproporphyrinogen oxidase

Acute attacks, Photosensitive skin lesions

Porphria variegate

Hepatic

AD

Protoporphyrinogen oxidase

Acute attacks, Photosensitive skin lesions

Porphyria cutana tarda

Hepatic

Acquired (rarely AD)

Urophorphyrin decarboxylase

Photosensitive skin lesions

Congenital erythropoietic porphyria

Erythroid

AR

Uroporphyrinogen cosynthase

Photosensitive skin lesions

Haemolytic anaemia

Splenomegaly

Erthropoietic protoporphyria

Erythroid

AD

Ferrochelatase

Photosensitive skin lesions

 

Erythroid porphyries

 

Congenital erythropoietic porphyria

  • Autosomal recessive  very rare
  • Photosensitive skin lesions which can be very disfiguring
  • Haemolytic anaemia
  • Splenomegaly

Treatment

  • Avoidance of sunlight
  • Splenectomy to improve haemolysis
  • High level blood transfusion to suppress erythropoiesis (combined with iron chelation) have been used to reduce pophyrin production to abolish clinical symptoms
  • Allogenic BMT

 

Eythropoietic porphyria

  • AD  more common
  • Ferrochelatase deficiency
  • Leads to increased protoporphyrin in bone marrow, red cells and bile
  • Variable clinical picture
  • Photosensitivity and dermatitis
  • Mild hypochromic anaemia with little haemolysis
  • Accumulation of protoporphyrins can occasionally lead to severe liver disease
  • Iron deficiency should be avoided

 

Acute porphyries

All except erythroid and PCT

Clinical features

  • Abdominal pain. Vomiting, diarrhoea
  • Pain, behavioural change, paralysis
  • Tachycardia and hypertension

 

  • Triggered by increased demand for hepatic haem (particularly the cytochrome P450 enzymes)
    • Alcohol, barbiturates, carbamazepine, phenytoin, rifampicin, sulphonamides
    • Cigarette smoking
  • Metabolic stress and surgery

Diagnosis

  • All porphyrias have a rise in urine porphyrobilinogen (apart from ALA, the first enzyme in the pathway in which ALA is increased and erythopoietic protoporphyrin, the last enzyme in the pathway where protoporphyrin is increased)

Treatment

  • Glucose  inhibits hepatic ALA synthetase
  • Hemin  suppresses hepatic ALA synthetase activity
  • Can return the porphyrobilinogen and other intermediate levels to normal very quickly

 

 

Disease

Compounds

Enzyme

 
 

Glycine and Succinyl CoA

 

image

 


Aminolevulinic acid synthase

Inhibited by Haem

 

Aminolevulinic acid (ALA)

 

image

ALA dehydrase deficiency


Aminolevulinic acid dehydrase

 
 

Porphobilinogen (PBG)

 

image

Acute intermittent porphyria (AIP)


Porphobilinogen deaminase

 
 

Hydroxymethylbilane

 

image

Congenital erythropoietic porphyria


Uroporphyrinogen co-synthase

 
 

Uroporphyrinogen III

 

image

Porphyria cutanea tarda (PCT)


Uroporphyringen decarboxylase

 
 

Coproporphyrinogen IIII

 

image

Heeditary coproporphyria (HCP)


Coproporphyrinogen oxidase

 
 

Protoporphyrinogen IX

 

image

Varieagate porphyria (VP)


Protoporphyrinogen oxidase

 
 

Protoporphyrin IX

 

image

Erythropoietic protoporphyria EPP


Ferrochelatase

 
 

Haeme

 

image

 


  
 

Haemoglobin

  

Comments